Related Experiment Video
Updated: Jul 9, 2025

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization
Published on: December 23, 2020
Expression of TRIM56 gene in SARS-CoV-2 variants and its relationship with progression of COVID-19
Rezvan Tavakoli1, Pooneh Rahimi1,2, Mojtaba Hamidi-Fard1,2
1Hepatitis & AIDS Department, Pasteur Institute of Iran, Tehran, Iran.
Aim:
The present study aimed to determine a correlation between differential TRIM56 expression levels and severe infections of COVID-19 between the Alpha, Delta and Omicron BA.5 variants.
Materials & Methods:
This study was performed on 330 COVID-19 patients, including 142 with severe and 188 with mild infections, as well as 160 healthy controls. The levels of TRIM56 gene expression were determined using a qPCR.
Results:
TRIM56 gene showed significantly lower mRNA expression in the severe and mild groups compared with healthy individuals. Our finding indicated the high and low reduction of TRIM56 mRNA expression in Delta and Omicron BA.5 variant, respectively.
Conclusion:
Further research is needed to characterize the impact of TRIM proteins on the severity of COVID-19.
Insights
Lower TRIM56 gene expression correlates with severe COVID-19, particularly with the Delta variant. This finding highlights TRIM56's potential role in disease severity across different SARS-CoV-2 variants.
Area of Science:
- Immunology
- Virology
- Genetics
Background:
- Severe COVID-19 is a global health concern.
- Understanding genetic factors influencing disease severity is crucial.
- The role of TRIM56 in SARS-CoV-2 infection requires further investigation.
Purpose of the Study:
- To investigate the correlation between TRIM56 gene expression and COVID-19 severity.
- To compare TRIM56 expression across different SARS-CoV-2 variants (Alpha, Delta, Omicron BA.5).
Main Methods:
- Quantitative real-time PCR (qPCR) was used to measure TRIM56 mRNA levels.
- The study included 330 COVID-19 patients (142 severe, 188 mild) and 160 healthy controls.
Main Results:
- TRIM56 mRNA expression was significantly lower in both severe and mild COVID-19 patients compared to healthy individuals.
- A high reduction in TRIM56 mRNA expression was observed in patients infected with the Delta variant.
- A low reduction in TRIM56 mRNA expression was observed in patients infected with the Omicron BA.5 variant.
Conclusions:
- Differential TRIM56 expression is associated with COVID-19 severity.
- TRIM56 may play a role in the varying severity observed with different SARS-CoV-2 variants.
- Further research is warranted to elucidate the precise mechanisms by which TRIM proteins influence COVID-19 outcomes.
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Viral Mutations
Leaky Scanning

